Molecular physiology of IGF-I expression

Journal of Pediatric Endocrinology and Metabolism

Volumn 15, Issue SUPPL. 5, 2002, Pages 1455-1458

  Rotwein, Peter ^a   Billiard, Julia ^a   Woelfle, Joachim ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

C EBP ; Growth hormone; IGF I; IGF I gene regulation; Osteoblasts; STAT proteins

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; JANUS KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PARATHYROID HORMONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE INHIBITOR; PROTEIN SHC; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN C; STAT PROTEIN; STAT5B PROTEIN; TRANSCRIPTION FACTOR; TYROSINE;

ARTICLE; BODY GROWTH; CELL DIFFERENTIATION; FETUS GROWTH; GENE CONTROL; GENE EXPRESSION REGULATION; GENE TARGETING; GROWTH RATE; HORMONAL REGULATION; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; LIGAND BINDING; NONHUMAN; OSTEOBLAST; POSTNATAL GROWTH; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE DIFFERENTIATION; TISSUE GROWTH; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CCAAT-ENHANCER-BINDING PROTEINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; JANUS KINASE 2; MILK PROTEINS; PARATHYROID HORMONE; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0036917523     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Salmon WD, Daughaday WH. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 1957; 49: 825-836.
2. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989; 10: 68-91.
3. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr). Cell 1993; 75: 59-72.
4. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillet N, Stewart TA. IGF-I is required for normal embryonic growth in mice. Genes Dev 1993; 7: 2609-2617.
5. Argetsinger LS, Carter-Su C. Mechanism of signaling by growth hormone receptor. Physiol Rev 1996; 76: 1089-1107.
6. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, Honjo M, Takahashi M, Takahashi T, Hirai H, Tushima T, Akanuma Y, Fujita T, Komuro I, Yazaki Y, Kadowaki T. Tyrosine phosphorylation of the EGF receptor by the kinase JAK2 is induced by growth hormone. Nature 1997; 390: 91-96.
7. Gronowski AM, Rotwein P. Rapid changes in nuclear protein tyrosine phosphorylation after growth hormone treatment in vivo. Identification of phosphorylated mitogen-activated protein kinase and STAT91. J Biol Chem 1994; 269: 7874-7878.
8. Gronowski AM, Zhong Z, Wen Z, Thomas MJ, Darnell JE Jr, Rotwein P. In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of Stat3. Mol Endocrinol 1995; 9: 171-177.
9. Campbell GS, Meyer DJ, Raz R, Levy DE, Schwartz J, Carter-Su C. Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone. J Biol Chem 1995; 270: 3974-3979.
10. Ram PA, Park SH, Choi HK, Waxman DJ. Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. J Biol Chem 1996; 271: 5929-5940.
11. Smit LS, Meyer DJ, Billestrup N, Norstedt G, Schwartz J, Carter-Su C. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3 and 5 by GH. Mol Endocrinol 1996; 10: 519-533.
12. Gebert CA, Park SH, Waxman DJ. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation. Mol Endocrinol 1997; 11: 400-414.
13. Zhang X, Blenis J, Li HC, Schindler C, Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 1995; 267: 1990-1994.
14. Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82: 241-250.
15. Darnell JE Jr. STATs and gene regulation. Science 1997; 277: 1630-1635.
16. Yoon JB, Berry SA, Seelig S, Towle HC. An inducible nuclear factor binds to a growth hormone-regulated gene. J Biol Chem 1990; 265: 19947-19954.
17. Bergad PL, Shih HM, Towle HC, Schwarzenberg SJ, Berry SA. Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites. J Biol Chem 1995; 270: 24903-24910.
18. Ooi GT, Hurst KR, Poy MN, Rechler MM, Boisclair YR. Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells. Mol Endocrinol 1998; 12: 675-687.
19. Subramanian A, Teixeira J, Wang J, Gil G. A STAT factor mediates the sexually dimorphic regulation of hepatic cytochrome P450 3A10/lithocholic acid 6beta-hydroxylase gene expression by growth hormone. Mol Cell Biol 1995; 15: 4672-4682.
20. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles on cytokine responses. Cell 1998; 93: 841-850.
21. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 1997; 94: 7239-7244.
22. McCarthy TL, Centrella M, Canalis E. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1989; 124: 1247-1253.
23. McCarthy TL, Centrella M, Canalis E. Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures. J Biol Chem 1990; 265: 15353-15356.
24. McCarthy TL, Centrella M, Raisz LG, Canalis E. Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1991; 128: 2895-2900.
25. Bichell DP, Rotwein P, McCarthy TL. Prostaglandin E2 rapidly stimulates insulin-like growth factor-I gene expression in primary rat osteoblast cultures: evidence for transcriptional control. Endocrinology 1993; 133: 1020-1028.
26. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamagauchi A. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 1997; 99: 2961-2970.
27. Miyakoshi N, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S. Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology 2001; 142: 4349-4356.
28. Ogata N, Chikazu D, Terauchi Y, Tobe K, Azuma Y, Ohta T, Kadowaki T, Nakamura K, Kawaguchi H. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 2000; 105: 935-943.
29. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH, Fagin JA, Clemens TL. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 2000; 141: 2674-2682.
30. Sims NA, Clement-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coschigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of STAT5. J Clin Invest 2000; 106: 1095-1103.
31. Thomas MJ, Umayahara Y, Shu H, Centrella M, Rotwein P, McCarthy TL. Identification of the CAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts. J Biol Chem 1996; 271: 21835-21841.
32. Umayahara Y, Ji C, Centrella M, Rotwein P, McCarthy TL. CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone. J Biol Chem 1997; 272: 31793-31800.
33. Umayahara Y, Billiard J, Ji C, Centrella M, McCarthy TL, Rotwein P. CCAAT/enhancer-binding protein delta is a critical regulator of insulin-like growth factor-I gene transcription in osteoblasts. J Biol Chem 1999; 274: 10609-10617.
34. Billiard J, Grewal SS, Lukaesko L, Stork PJ, Rotwein P. Hormonal control of insulin-like growth factor I gene transcription in human osteoblasts: dual actions of cAMP-dependent protein kinase on CCAAT/enhancer-binding protein delta. J Biol Chem 2001; 276: 31238-31246.